跳至主要内容
临床试验/JPRN-jRCT2031210266
JPRN-jRCT2031210266进行中(未招募)3 期

A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of SR-0379 in Participants with Skin Ulcer

Ichioka Shigeru0 个研究点目标入组 120 人开始时间: 2021年8月20日最近更新:
适应症

试验速览

阶段
3 期
状态
进行中(未招募)
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 18age old 至 < 85age old(—)
性别
All

入选标准

  • Patients must have a wound requiring wound bed preparation in advance of planned surgical closure (including suturing, grafts or flaps)

排除标准

  • Presence of untreated ulcer infection (redness, swelling, pus, foul odor, fever)

研究者

发起方
Ichioka Shigeru

相似试验

进行中(未招募)
1 期
A Phase 3 Study of Guselkumab in Subjects with Active Psoriatic Arthritis
EUCTR2016-001163-37-PLJanssen-Cilag International N.V.360
进行中(未招募)
1 期
Phase 3 study of ALZ-801 in patients with early Alzheimer's Disease and APOE4/4 genotypeEarly Alzheimer’s Disease (AD)MedDRA version: 20.0Level: HLTClassification code 10001897Term: Alzheimer's disease (incl subtypes)System Organ Class: 100000004852
EUCTR2020-005755-20-CZAlzheon, Inc.300
进行中(未招募)
1 期
A Study on the Effect of E5501 (study drug) in Adults with Chronic Immune ThrombocytopeniaChronic Immune Thrombocytopenia (Idiopathic Thrombocytopenic Purpura)MedDRA version: 14.1Level: HLGTClassification code 10035534Term: Platelet disordersSystem Organ Class: 10005329 - Blood and lymphatic system disordersMedDRA version: 14.1Level: PTClassification code 10043554Term: ThrombocytopeniaSystem Organ Class: 10005329 - Blood and lymphatic system disordersMedDRA version: 14.1Level: LLTClassification code 10036735Term: Primary thrombocytopeniaSystem Organ Class: 10005329 - Blood and lymphatic system disordersMedDRA version: 14.1Level: SOCClassification code 10005329Term: Blood and lymphatic system disordersSystem Organ Class: 10005329 - Blood and lymphatic system disorders
EUCTR2011-000830-12-BEEisai Limited84
已完成
3 期
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Oral RPC1063 as Induction and Maintenance Therapy for Moderate to Severe Ulcerative Colitischronic inflammation of the mucous membrane of the large intestineinflammatory bowel disease10017969
NL-OMON47446Celgene International II Sarl (CIS II)33
已完成
3 期
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Safety and Efficacy Study of Linaclotide Administered Orally to Children, Ages 6 to 17 Years, With Functional Constipation (FC)and painful defecationinfrequenthard stools10002112Functional Constipation
NL-OMON52398AbbVie Deutschland GmbH & Co. KG15